Gastric Cancer: Update on First-Line Therapies

Onco - Update 2024 in GI & Hepatobiliary Cancers - 19th DecПодробнее

Tislelizumab in First-Line Treatment for Advanced Gastric Cancer #oncology #pencis #lecture #AntiPD1Подробнее

Bringing Treatment Into Focus: Biomarker-Driven First-Line Therapy for Metastatic Gastric/GEJ Can...Подробнее

Beyond the Horizon in Gastric Cancer: Updated Evidence on How Systemic Therapies Are Redefining CareПодробнее

36 First Line Therapy: Monitoring Success, Maintenance, & Disease ProgressionПодробнее

Clinical Trials Updates for Gastric Cancer Patients WebinarПодробнее

38 Second Line & Later Therapy for HER2+Подробнее

Dr. Akihito Kawazoe on Regorafenib and Nivolumab for Advanced Gastric Cancer | OncoDailyПодробнее

Clinical Trial Updates for Gastric CancerПодробнее

GI Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Mark LewisПодробнее

35 First Line Therapy for HER2-, PDL1-, CLDN18.2- GEAПодробнее

32 First Line Therapy for HER2+ GEAПодробнее

ASCO 2023 Updates WebinarПодробнее

31 First Line Therapy: The Role of Biomarkers and NCCN GuidelinesПодробнее

Non-Hodgkin Lymphoma: First Symptoms, Diagnosis & the LATEST Treatments | The Patient StoryПодробнее

First-Line Immunotherapy in Upper GI Cancer: Recent UpdatesПодробнее

Breaking Barriers: KEYTRUDA Triumphs as First-Line Treatment for HER2-Positive Gastric CancerПодробнее

Advanced gastric and gastroesophageal cancer in AsiaПодробнее

34 First Line Therapy for HER2- PDL1- CLDN18.2+ GEAПодробнее

33 First Line Therapy for HER2- PDL1+ GEAПодробнее